Fungal Infections in Liver Transplant Recipients
- PMID: 34210106
- PMCID: PMC8304186
- DOI: 10.3390/jof7070524
Fungal Infections in Liver Transplant Recipients
Abstract
Invasive fungal infections (IFIs) are one of the most feared complications associated with liver transplantation, with high rates of morbidity and mortality. We discuss the most common invasive fungal infections in the setting of liver transplant, including Candida, Aspergillus, and Cryptococcal infections, and some less frequent but devastating mold infections. Further, we evaluate the use of prophylaxis to prevent invasive fungal infection in this population as a promising mechanism to reduce risks to patients after liver transplant.
Keywords: Aspergillus; candidiasis; cryptococcosis; invasive fungal infection; liver transplant.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.Transpl Infect Dis. 2020 Dec;22(6):e13361. doi: 10.1111/tid.13361. Epub 2020 Jun 22. Transpl Infect Dis. 2020. PMID: 32510755
-
Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.Clin Infect Dis. 2020 Jan 1;70(1):30-39. doi: 10.1093/cid/ciz156. Clin Infect Dis. 2020. PMID: 30801642 Free PMC article.
-
Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.Chin Med J (Engl). 2008 Apr 5;121(7):625-30. Chin Med J (Engl). 2008. PMID: 18466683
-
Clinical aspects of invasive candidiasis in solid organ transplant recipients.Drugs. 2009;69 Suppl 1:15-20. doi: 10.2165/11315510-000000000-00000. Drugs. 2009. PMID: 19877729 Review.
-
Fungal infections in solid organ transplantation.Med Mycol. 2007 Jun;45(4):305-20. doi: 10.1080/13693780701200372. Med Mycol. 2007. PMID: 17510855 Review.
Cited by
-
Severe midface necrosis after liver failure induced fungal infection: A case report on the outcome after reconstruction.Int J Surg Case Rep. 2023 Sep;110:108726. doi: 10.1016/j.ijscr.2023.108726. Epub 2023 Sep 4. Int J Surg Case Rep. 2023. PMID: 37678032 Free PMC article.
-
Lipid-Based Nanotechnology: Liposome.Pharmaceutics. 2023 Dec 26;16(1):34. doi: 10.3390/pharmaceutics16010034. Pharmaceutics. 2023. PMID: 38258045 Free PMC article. Review.
-
Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients.J Fungi (Basel). 2023 Feb 18;9(2):272. doi: 10.3390/jof9020272. J Fungi (Basel). 2023. PMID: 36836384 Free PMC article.
-
Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species.Microbiol Spectr. 2022 Aug 31;10(4):e0124022. doi: 10.1128/spectrum.01240-22. Epub 2022 Jul 25. Microbiol Spectr. 2022. PMID: 35876581 Free PMC article.
-
The Role of Frequent Screening or Diagnostic Testing of Serum Cryptococcal Antigen in Liver Transplant Recipients: A Descriptive Epidemiology.Open Forum Infect Dis. 2024 May 17;11(5):ofae255. doi: 10.1093/ofid/ofae255. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38774792 Free PMC article.
References
-
- Singh N., Avery R.K., Munoz P., Pruett T.L., Alexander B., Jacobs R., Tollemar J.G., Dominguez E.A., Yu C.M., Paterson D.L., et al. Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients. Clin. Infect. Dis. 2003;36:46–52. doi: 10.1086/345441. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources